MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...

Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...

India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country.The company had obtained regulatory approval ...

Cipla, a global leader in inhalation therapies, on Monday announced the launch of Afrezza, the world's only rapid-acting inhaled insulin, in the Indian market.